25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men

Neurology

Volumn 74, Issue 1, 2010, Pages 33-41

  Slinin, Y ^a,c   Paudel, M L ^d   Taylor, B C ^a,c,d   Fink, H A ^a,b,c,d   Ishani, A ^a,c   Canales, M T ^e,f   Yaffe, K ^g,h   Barrett Connor, E ^g   Orwoll, E S ⁱ   Shikany, J M ^k   Leblanc, E S ^j   Cauley, J A ^l   Ensrud, K E ^a,c,d  

^a Center for Chronic Disease Outcomes Research   (United States)

^b GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^c VA MEDICAL CENTER   (United States)

^d Department of Medicine ^*

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^k University of Alabama at Birmingham   (United States)

^l UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

AGED; ARTICLE; COGNITION; COGNITIVE DEFECT; EDUCATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PSYCHOLOGIC TEST; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANIMAL; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; DEMOGRAPHY; FRACTURE; GERIATRIC ASSESSMENT; MENTAL HEALTH; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; ANIMALS; COGNITION DISORDERS; COHORT STUDIES; FRACTURES, BONE; GERIATRIC ASSESSMENT; HUMANS; MALE; MENTAL STATUS SCHEDULE; MODELS, STATISTICAL; NEUROPSYCHOLOGICAL TESTS; ODDS RATIO; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; VITAMIN D;

EID: 74049134320     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181c7197b     Document Type: Article

References (41)

1. Gloth FM III, Gundberg CM, Hollis BW, Haddad JG Jr, Tobin JD. Vitamin D deficiency in homebound elderly persons. JAMA 1995;274:1683-1686.
2. Goldray D, Mizrahi-Sasson E, Merdler C, et al. Vitamin D deficiency in elderly patients in a general hospital. J Am Geriatr Soc 1989;37:589-592.
3. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypo-vitaminosis D in medical inpatients. N Engl J Med 1998; 338:777-783.
4. Zadshir A, Tareen N, Pan D, Norris K, Martins D. The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis 2005;15:S5-S101.
5. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-281.
6. Buell JS, Scott TM, Dawson-Hughes B, et al. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 2009;64: 888-895.
7. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293:2257-2264.
8. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007;49:1063-1069.
9. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117:503-511.
10. Frazer TE, White NH, Hough S, et al. Alterations in circulating vitamin D metabolites in the young insulin-dependent diabetic. J Clin Endocrinol Metab 1981;53: 1154-1159.
11. Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mau-ricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 2008;10:185-197.
12. Li H, Stampfer MJ, Hollis JB, et al. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med 2007;4:e103.
13. Giovannucci E. Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol 2009;19:84-88.
14. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005;29: 21-30.
15. Baas D, Prufer K, Ittel ME, et al. Rat oligodendrocytes express the vitamin D(3) receptor and respond to 1,25-dihydroxyvitamin D(3). Glia 2000;31:59-68.
16. Prufer K, Veenstra TD, Jirikowski GF, Kumar R. Distribution of 1,25-dihydroxyvitamin D3 receptor immunore-activity in the rat brain and spinal cord. J Chem Neuroanat 1999;16:135-145. (Pubitemid 29155499)
17. Magrassi L, Bono F, Milanesi G, Butti G. Vitamin D receptor expression in human brain tumors. J Neurosurg Sci 1992;36:27-30.
18. Stumpf WE, O'Brien LP. 1,25 (OH)2 vitamin D3 sites of action in the brain: an autoradiographic study. Histochem-istry 1987;87:393-406.
19. Veenstra TD, Prufer K, Koenigsberger C, Brimijoin SW, Grande JP, Kumar R. 1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo. Brain Res 1998;804:193-205.
20. McGrath JJ, Feron FP, Burne TH, Mackay-Sim A, Eyles DW. Vitamin D3-implications for brain development. J Steroid Biochem Mol Biol 2004;89-90:557-560.
21. Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F. Vitamin D3 and brain development. Neuroscience 2003; 118:641-653.
22. Ibi M, Sawada H, Nakanishi M, et al. Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glu-tamate and reactive oxygen species in mesencephalic culture. Neuropharmacology 2001;40:761-771.
23. Brewer LD, Thibault V, Chen KC, Langub MC, Land-field PW, Porter NM. Vitamin D hormone confers neuro-protection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci 2001;21:98-108.
24. Neveu I, Naveilhan P, Jehan F, et al. 1,25-Dihydroxy-vitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Res Mol Brain Res 1994;24:70-76.
25. Kalueff AV, Lou YR, Laaksi I, Tuohimaa P. Increased anxiety in mice lacking vitamin D receptor gene. Neuroreport 2004;15:1271-1274. (Pubitemid 38757262)
26. Jorde R, Waterloo K, Saleh F, Haug E, Svartberg J. Neuro-psychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels: the Tromso study. J Neurol 2006;253:464-470.
27. Wilkins CH, Birge SJ, Sheline YI, Morris JC. Vitamin D deficiency is associated with worse cognitive performance and lower bone density in older African Americans. J Natl Med Assoc 2009;101:349-354.
28. Przybelski RJ, Binkley NC. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 2007;460:202-205.
29. Lee DM, Tajar A, Ulubaev A, et al. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neuro-surg Psychiatry 2009;80:722-729.
30. McGrath J, Scragg R, Chant D, Eyles D, Burne T, Ob-radovic D. No association between serum 25-hydroxyvitamin D3 level and performance on psychometric tests in NHANES III. Neuroepidemiology 2007;29:49-54.
31. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006;14:1032-1040.
32. Blank JB, Cawthon PM, Carrion-Petersen ML, et al. Overview of recruitment for the Osteoporotic Fractures in Men Study (MrOS). Contemp Clin Trials 2005;26:557-568.
33. Orwoll E, Blank JB, Barrett-Connor E, et al. Design and baseline characteristics of the Osteoporotic Fractures in Men (MrOS) Study: a large observational study of the determinants of fracture in older men. Contemp Clin Trials 2005;26:569-585.
34. Singh RJ, Taylor RL, Reddy GS, Grebe SK. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 2006;91:3055-3061.
35. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-318.
36. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8: 271-276.
37. Kurella M, Chertow GM, Fried LF, et al. Chronic kidney disease and cognitive impairment in the elderly: the Health, Aging, and Body Composition Study. J Am Soc Nephrol 2005;16:2127-2133.
38. Washburn RA, Smith KW, Jette AM, Janney CA. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 1993;46:153-162.
39. Ware JE, Kosinski M, Keller SD. SF-12: How to Score the SF-12 Physical and Mental Health Summary Scores, 3rd ed. Lincoln, RI: QualityMetric, Inc.; 1998.
40. Fitti JE, Kovar MG. The Supplement on Aging to the 1984 National Health Interview Survey. Vital Health Stat 1 1987;(21):1-115.
41. Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hum-mon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983;26:1346-1353.